Healio

GLP-1s may be more cardioprotective vs. other glucose-lowering agents for diabetes

Please provide your email address to receive an email when new articles are posted on . GLP-1s may be the most cardioprotective glucose-lowering agents for patients with type 2 diabetes. Their effect ...
Renal & Urology News

KRT Risk Lower With SGLT2 Inhibitor vs GLP-1 Receptor Agonist Use in Diabetic CKD

Use of SGLT2 inhibitors rather than GLP-1 receptor agonists is associated with lower risk of progression to kidney replacement therapy among patients with type 2 diabetes and CKD. The risk of ...
Healio

GLP-1s & cancer: Data show survival benefit, reveal gap in patient-clinician communication

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. GLP-1 receptor agonists reduced mortality vs. DDP-4 ...
Medscape

SGLT2i/GLP-1 Combo More Kidney-Protective Than Solo Therapy

In the prevention of kidney disease in patients with type 2 diabetes (T2D) and mildly reduced kidney function, SGLT2 inhibitors (SGLT2i) showed a stronger benefit than GLP-1 receptor agonists (RA) and ...